# Value-Based Medicine (VBM) for Lung Cancer

> **NCT06703866** · — · UNKNOWN · sponsor: **European Institute of Oncology** · enrollment: 200 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** Non Small Cell Lung Cancer (NSCLC)

## Key facts

- **NCT ID:** NCT06703866
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-27
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06703866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06703866, "Value-Based Medicine (VBM) for Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06703866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*